ARTICLE
13 March 2014

New York District Court Dismisses Putative ERISA Class Alleging Illegal Kickbacks

B
BakerHostetler

Contributor

BakerHostetler logo
Recognized as one of the top firms for client service, BakerHostetler is a leading national law firm that helps clients around the world address their most complex and critical business and regulatory issues. With five core national practice groups — Business, Labor and Employment, Intellectual Property, Litigation, and Tax — the firm has more than 970 lawyers located in 14 offices coast to coast. BakerHostetler is widely regarded as having one of the country’s top 10 tax practices, a nationally recognized litigation practice, an award-winning data privacy practice and an industry-leading business practice. The firm is also recognized internationally for its groundbreaking work recovering more than $13 billion in the Madoff Recovery Initiative, representing the SIPA Trustee for the liquidation of Bernard L. Madoff Investment Securities LLC. Visit bakerlaw.com
Sometimes in the rush to meet Rule 23(a) and (b)’s requirements, what gets overlooked is whether there is any underlying claim in the first place.
United States Litigation, Mediation & Arbitration

Sometimes in the rush to meet Rule 23(a) and (b)'s requirements, what gets overlooked is whether there is any underlying claim in the first place.  In a refreshing opinion, the Southern District of New York disposed of a claimed ERISA class action for the reason that, irrespective of any class allegations, the defendant was not alleged to have done anything illegal.  In Skin Pathology Associates, Inc. v. Morgan Stanley & Co., Case No. 1:13-cv-03299-AT (S.D.N.Y. Feb. 24, 2014), the plaintiff established a 401(k) plan for its employees, and retained Morgan Stanley to provide the program in which the 401(k) funds were to be invested.  Morgan Stanley, in turn, hired ING to perform investment and recordkeeping services.  So far, nothing controversial.

Where the issue arose, however, was that ING and others were to pay Morgan Stanley a fee, termed a "kickback" by the court, based on the amount of money actually invested in the 401(k) accounts.  Importantly, this fee was not paid from the plan assets, but, rather, by ING itself.  Just as importantly (at least from a practical standpoint), the existence of the fee was disclosed in the financial disclosure statements the plaintiffs signed when they retained Morgan Stanley as investment manager.  The plaintiffs brought a putative class action asserting that these arrangements were prohibited transactions under ERISA.

As to the merits, the court had first to parse through ERISA and the complaint to determine the nature of the claimed violation.  It addressed difficulties arising from the statutory language and the fact that the kickbacks were not being paid from plan funds.  It ultimately concluded, perhaps a little reluctantly, that the arrangement would have been illegal only if it had not been disclosed.  The court found, however, that the plaintiffs were challenging the arrangement itself, not a failure to disclose it, and that in any case it appeared that it had been disclosed.  Thus, the court dismissed the complaint without leave to amend.

The Skin Pathology case is important because it reflects a court addressing the merits early on rather than awaiting lengthy and expensive discovery before making a ruling.   As it followed from the court's analysis, no class, however constituted, would have had a claim.  One can only imagine the discovery costs alone had the parties been required to undertake class-wide discovery on likely thousands of 401(k) plans had the court awaited discovery to dispose of the claims.

The Bottom Line:  Some class actions are best dealt with at the pleading stage rather than after extensive discovery.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More